There's a reason why Claire Shipman, acting president of Columbia University, cut a deal with Secretary of Education Linda McMahon last week. Elite universities like to pose as protectors of free ...

The newly released American Eagle commercials with Sydney Sweeney are not the kind of thing a major U.S. brand would have ...

Despite Democrats’ hopes, the Epstein files saga won’t separate Trump from his base. Trump’s supporters have stuck with him through far worse over the last 10 years. Not only have they “stuck,” they ...

My friend Kurt Schlichter, in a column at Townhall earlier this week, was spot-on in defense of gerrymandering as a political act, and in advocating its aggressive use in red states: Gerrymandering is ...

California’s progressive Democratic majority just can’t get over its ill-fated, yearslong failure to crush the burgeoning ridesharing industry — even after the state Supreme Court last year upheld a ...

President Donald Trump announced that a 25 percent blanket tariff on imports from India will come into effect on Aug. 1, 2025. Trump noted the high tariff rates India maintains on the import of ...

Simply reading mainstream coverage, one might conclude that the flurry of progressive outrage over “masked ICE agents” had died down as the outrage machine moved along to other targets such as ...

I woke up on Monday to the promising news that President Donald Trump had helped broker an end to the bloody border conflict between Thailand and Cambodia that has already killed 36 soldiers and ...

Vice President JD Vance has castigated U.S. tech companies for laying off thousands of American workers to replace them with ...

Emmanuel and Brigitte Macron, the president and first lady of France, filed a lawsuit on Wednesday against podcaster Candace ...

Despite the Left’s continued systemic attack on the institution of marriage, a recent report suggests that new marriages are stronger than in past decades. According to the Family Studies Institute, ...

The American Academy of Pediatrics lit the fuse in 2023. Their recommendation to use GLP-1 weight-loss drugs in children and adolescents wasn’t just a nod to pharmaceutical innovation — it was a ...